Symptom improvement and predictors associated with improvement after 6 weeks of alpha-blocker therapy: An exploratory, single-arm, open-label cohort study

OBJECTIVES: Clinicians should not only know how many patients will benefit from alpha-blocker therapy but should also be able to identify who will benefit. We studied the changes in patient symptoms following alpha-blocker therapy and the predictors of symptom improvement in clinical practice. DESIG...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Worp, Henk, Kollen, Boudewijn J., Vermist, Tom, Steffens, Martijn G., Blanker, Marco H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657904/
https://www.ncbi.nlm.nih.gov/pubmed/31344100
http://dx.doi.org/10.1371/journal.pone.0220417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657904/
https://www.ncbi.nlm.nih.gov/pubmed/31344100
http://dx.doi.org/10.1371/journal.pone.0220417

Ejemplares similares